Amalgamated Bank lowered its stake in shares of UiPath, Inc. (NYSE:PATH – Free Report) by 23.3% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 22,199 shares of the company’s stock after selling 6,725 shares during the quarter. Amalgamated Bank’s holdings in UiPath were worth $284,000 as of its most recent SEC filing.
A number of other institutional investors also recently modified their holdings of PATH. Teacher Retirement System of Texas increased its holdings in shares of UiPath by 83.4% in the first quarter. Teacher Retirement System of Texas now owns 78,485 shares of the company’s stock valued at $808,000 after purchasing an additional 35,697 shares in the last quarter. Envestnet Asset Management Inc. boosted its position in UiPath by 52.1% in the 1st quarter. Envestnet Asset Management Inc. now owns 107,087 shares of the company’s stock valued at $1,103,000 after buying an additional 36,674 shares during the last quarter. Xponance Inc. increased its stake in shares of UiPath by 2.0% in the 1st quarter. Xponance Inc. now owns 54,246 shares of the company’s stock valued at $559,000 after buying an additional 1,054 shares during the period. Edgestream Partners L.P. raised its position in shares of UiPath by 311.7% during the first quarter. Edgestream Partners L.P. now owns 802,046 shares of the company’s stock worth $8,261,000 after acquiring an additional 607,243 shares during the last quarter. Finally, OVERSEA CHINESE BANKING Corp Ltd lifted its stake in shares of UiPath by 33.6% during the first quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 19,905 shares of the company’s stock valued at $205,000 after acquiring an additional 5,010 shares during the period. 62.50% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
A number of analysts recently commented on PATH shares. Canaccord Genuity Group lowered their price objective on UiPath from $16.00 to $15.00 and set a “buy” rating for the company in a research report on Monday, September 8th. Wall Street Zen lowered shares of UiPath from a “strong-buy” rating to a “buy” rating in a research note on Saturday, October 25th. Needham & Company LLC reiterated a “hold” rating on shares of UiPath in a research report on Friday, September 5th. DA Davidson began coverage on shares of UiPath in a report on Friday, September 5th. They issued a “neutral” rating and a $12.00 price objective on the stock. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of UiPath in a research note on Thursday, October 30th. Two analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $13.71.
Insiders Place Their Bets
In related news, CEO Daniel Dines sold 45,000 shares of the firm’s stock in a transaction dated Wednesday, November 5th. The shares were sold at an average price of $15.07, for a total transaction of $678,150.00. Following the transaction, the chief executive officer directly owned 29,288,585 shares of the company’s stock, valued at $441,378,975.95. This trade represents a 0.15% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CAO Hitesh Ramani sold 5,000 shares of UiPath stock in a transaction that occurred on Wednesday, October 22nd. The stock was sold at an average price of $15.47, for a total transaction of $77,350.00. Following the transaction, the chief accounting officer directly owned 182,776 shares in the company, valued at approximately $2,827,544.72. This represents a 2.66% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 2,319,002 shares of company stock valued at $34,094,875 over the last three months. 23.19% of the stock is currently owned by insiders.
UiPath Stock Up 1.2%
NYSE PATH opened at $14.32 on Friday. UiPath, Inc. has a 52 week low of $9.38 and a 52 week high of $18.74. The business has a 50 day moving average price of $13.91 and a 200-day moving average price of $12.78. The company has a market cap of $7.60 billion, a price-to-earnings ratio of 477.17, a P/E/G ratio of 5.29 and a beta of 1.09.
UiPath (NYSE:PATH – Get Free Report) last posted its quarterly earnings results on Thursday, September 4th. The company reported $0.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.08 by $0.07. UiPath had a net margin of 1.35% and a return on equity of 1.28%. The business had revenue of $361.73 million during the quarter, compared to the consensus estimate of $347.36 million. During the same quarter last year, the firm posted $0.04 EPS. UiPath’s revenue was up 14.6% compared to the same quarter last year. UiPath has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. On average, equities research analysts anticipate that UiPath, Inc. will post -0.17 earnings per share for the current year.
About UiPath
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Featured Articles
- Five stocks we like better than UiPath
- How to trade using analyst ratings
- Rivian’s Chart Says Go, But Some Analysts Still Say No
- How to start investing in penny stocks
- e.l.f. Sell-Off Is a Good Time to Buy, According to Analysts
- Insider Buying Explained: What Investors Need to Know
- T-Mobile Is The Most Oversold Mega-Cap Stock—Time to Buy?
Want to see what other hedge funds are holding PATH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UiPath, Inc. (NYSE:PATH – Free Report).
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.
